DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Acceleron Pharma Inc. (XLRN)
« Back to company indexXLRN Chatter Timeline
Stock Ticker for XLRN
Most Active Tweeters for XLRN
| User | Tweets |
|---|---|
| @Tickeron | 10 |
| @newsfilterio | 8 |
| @Biotech2050 | 5 |
| @TranscriptDaily | 5 |
| @Gambiste1 | 4 |
Recent Tweets for XLRN
 |
@YuZhu4 RT @semodough: Piper $XLRN like the risk/reward set-up for PoC data with sotatercept in PAH which are expected in 1Q20. Regardless of tsota… 4:01pm |
 |
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/6oDjPEYgKH 12:01pm |
 |
@Gambiste1 RT @IlliniJJ: $XLRN Topline results from the PULSAR Phase 2 trial in patients with PAH are expected in the first quarter of 2020. In prec… 12:01pm |
 |
@semodough Piper $XLRN like the risk/reward set-up for PoC data with sotatercept in PAH which are expected in 1Q20. Regardless… https://t.co/QnQsDcaZP6 12:01pm |
 |
@IlliniJJ $XLRN Topline results from the PULSAR Phase 2 trial in patients with PAH are expected in the first quarter of 2020… https://t.co/PlpANU4fJw 12:01pm |
 |
@TickerReport ValuEngine Lowers Acceleron Pharma $XLRN to Hold https://t.co/eMcJHRhdpd 6:01am |
 |
@bbnsnews ValuEngine Lowers Acceleron Pharma $XLRN to Hold https://t.co/bW86bTlyE1 6:01am |
 |
@EnterpriseLeade Zacks Investment Research Lowers Acceleron Pharma $XLRN to Sell https://t.co/YFpEd1WbUu 6:01am |
|
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/jajINpGqdZ January 19th 2020, 12:01pm |
 |
@TranscriptDaily Analysts Set Acceleron Pharma Inc $XLRN Target Price at $59.10 https://t.co/PlOca2dCN3 January 19th 2020, 11:01am |
 |
@ConsumerFeed Acceleron Pharma $XLRN Downgraded by ValuEngine https://t.co/kfvyPCJQgY January 19th 2020, 10:01am |
|
@Gambiste1 RT @msmoneymoves: Our weekend at @MSMoneyMoves has been full of new coverage for our clinical pipeline score! We just went live with $XLRN… January 19th 2020, 10:01am |
 |
@newsfilterio Acceleron Pharma Downgraded by ValuEngine to Hold $XLRN https://t.co/XnkuWzV76F January 18th 2020, 4:01pm |
|
@newsfilterio Rhenman & Partners Asset Management AB Boosts Stock Position in Acceleron Pharma Inc $XLRN https://t.co/OticSwmO52 January 18th 2020, 12:01pm |
|
@YuZhu4 RT @semodough: Hcw $XLRN believe drug is safe and effective,expect approval in MDS at least by PDUFA date of April 4, 2020, or perhaps befo… January 18th 2020, 11:01am |
|
@semodough Hcw $XLRN believe drug is safe and effective,expect approval in MDS at least by PDUFA date of April 4, 2020, or per… https://t.co/rSWYCmTB2x January 18th 2020, 9:01am |
 |
@ZolmaxNews ValuEngine Downgrades Acceleron Pharma $XLRN to Hold https://t.co/sAeXjdQLdC January 18th 2020, 1:01am |
|
@TranscriptDaily Acceleron Pharma $XLRN Downgraded by ValuEngine to Hold https://t.co/8HsIDIgFPp January 17th 2020, 10:01pm |
 |
@WeekHerald Acceleron Pharma $XLRN Downgraded to Sell at Zacks Investment Research https://t.co/5AyTinxEX1 January 17th 2020, 10:01pm |
 |
@stocknewstimes Acceleron Pharma $XLRN Downgraded by ValuEngine to Hold https://t.co/9AKwOEcyOe January 17th 2020, 10:01pm |
 |
@dakotafinancial Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/GpWXRq3ZOY January 17th 2020, 9:01pm |
|
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/fJBDLwojXr January 17th 2020, 1:01pm |
|
@newsfilterio The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom.. $XLRN… https://t.co/3UXPc5KDN2 January 17th 2020, 8:01am |
|
@newsfilterio The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom D.. $XLRN… https://t.co/VNsjR1FHch January 17th 2020, 8:01am |
 |
@gcassidy718 $XLRN Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 3.83 % change recently https://t.co/Cjbv1BHC3y January 16th 2020, 4:01pm |
|
@stocknewstimes Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/VU1BSMAwAS January 16th 2020, 4:01pm |
 |
@TheMarketsDaily Zacks Investment Research Downgrades Acceleron Pharma $XLRN to Sell https://t.co/nWLwF6lUDu January 16th 2020, 4:01pm |
|
@Tickeron $XLRN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on January 9, 2020. View odds… https://t.co/jeyz8bh0Cn January 16th 2020, 2:01pm |
|
@IlliniJJ $XLRN - another nice move today https://t.co/dl4FjnHDtJ January 16th 2020, 11:01am |
|
@TranscriptDaily Acceleron Pharma $XLRN Reaches New 1-Year High at $56.90 https://t.co/PEuKigCN6s January 16th 2020, 10:01am |
 |
@AmericanBanking Acceleron Pharma Inc $XLRN Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/xyE2PLHGd4 #stocks January 16th 2020, 10:01am |
 |
@LargeVoidBot 09:51 New 52wk Highs: $XLRN January 16th 2020, 9:01am |
 |
@Biotech2050 Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes $XLRN $BMY https://t.co/QRm3ZzROwd January 15th 2020, 11:01pm |
 |
@SeekingAlpha $XLRN - Acceleron Pharma (XLRN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow. Subscribe to… https://t.co/zQHJ5zCoUS January 14th 2020, 2:01pm |
 |
@BlueBioNow $XLRN What happened??? why the bounce?? -5.59 % change recently https://t.co/gR0MpM5fid January 13th 2020, 5:01pm |
|
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/GhAC7Oj7t4 January 13th 2020, 1:01pm |
|
@YuZhu4 RT @Biotech2050: $BMY's 2021 opportunities - includes $XLRN's drug #JPM20 https://t.co/ydJ2bywDr8 January 13th 2020, 1:01pm |
|
@Biotech2050 $BMY's 2021 opportunities - includes $XLRN's drug #JPM20 https://t.co/ydJ2bywDr8 January 13th 2020, 1:01pm |
|
@Biotech2050 #JPM20 $XLRN $GILD webcasts started at the same time! January 13th 2020, 12:01pm |
|
@ConsumerFeed Zacks: Analysts Expect Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $32.58 Million https://t.co/yuqcZQl2zm January 12th 2020, 6:01pm |
 |
@dispatchtribune $32.58 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/AMGteJPeDr January 12th 2020, 6:01pm |
 |
@tradersreport RT @Tickeron: $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for this and oth… January 12th 2020, 2:01pm |
|
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on January 9, 2020. View odds for th… https://t.co/QHhpjtt7rQ January 12th 2020, 2:01pm |
|
@Gambiste1 RT @AcceleronPharma: Just touched down in #SFO. Check out our presentation tomorrow at 9:30 am PT $XLRN #JPM20 January 12th 2020, 1:01pm |
 |
@AcceleronPharma Just touched down in #SFO. Check out our presentation tomorrow at 9:30 am PT $XLRN #JPM20 January 12th 2020, 12:01pm |
|
@gcassidy718 $XLRN what a Company -5.59 % change recently https://t.co/Cjbv1BHC3y January 11th 2020, 10:01pm |
 |
@ThisLincolnian Acceleron Pharma $XLRN Hits New 52-Week High at $55.37 https://t.co/twqDTMmARg January 11th 2020, 2:01am |
|
@BlueBioNow $XLRN might be worth taking a position when this bottoms -2.35 % change recently https://t.co/gR0MpM5fid January 10th 2020, 11:01pm |
|
@TheMarketsDaily $32.58 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/COgtOh75r6 January 10th 2020, 11:01pm |
|
@TranscriptDaily -$0.30 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/uN2AnbpEU6 January 10th 2020, 11:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.